Status:

TERMINATED

Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Treatment-Resistant Keratitis

Lead Sponsor:

TBF Genie Tissulaire

Conditions:

Keratitis

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

Brief Summary

The purpose of this open, mono center trial is to assess the impact of the use of an amniotic membrane on the healing of a keratitis resistant to medical treatment.

Eligibility Criteria

Inclusion

  • Male or female; age between 18 and 65 years.
  • Patient with non-infectious keratitis resistant to medical treatment for more than 15 days or recurrent after healing treatment.
  • Patient with quantitative and qualitative score for inflammatory ocular signs \> 20.
  • Patient with Oxford grade \> 2.
  • Informed and consenting patient with a relative or friend available to instill eye drops if necessary.
  • Patient affiliated to a social security system or beneficiary of such a system.

Exclusion

  • Patient with active infectious keratitis (bacterial, parasitic or viral).
  • Patient with allergy to Oxybuprocaine or Tetracaine eye drops, to ester type local anesthetics and to fluorescein.
  • Current contact lens wear, including scleral lenses.
  • NSAID eye drops and any drops containing preservatives.
  • Antibiotic, anti-viral, anti-parasitic eye drops.
  • Patient with identified causes for the keratitis for which discontinuation of medical treatment beneficial.
  • Ocular surgery in the 3 months preceding the inclusion in the study.
  • Monophtalmic patient.
  • Person deprived of liberty by a judicial or administrative decision.
  • Adult subjected to a legal protection measure or unable to express his/her consent.

Key Trial Info

Start Date :

June 29 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 7 2021

Estimated Enrollment :

5 Patients enrolled

Trial Details

Trial ID

NCT05250583

Start Date

June 29 2020

End Date

January 7 2021

Last Update

November 14 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU de Saint-Etienne Hôpital Nord

Saint-Priest-en-Jarez, France, 42270

Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Treatment-Resistant Keratitis | DecenTrialz